Cleared Traditional

K982226 - UROMED BRACHYTHERAPHY IODINE-125 SOURCES
(FDA 510(k) Clearance)

May 1999
Decision
323d
Days
Class 2
Risk

K982226 is an FDA 510(k) clearance for the UROMED BRACHYTHERAPHY IODINE-125 SOURCES. This device is classified as a Source, Brachytherapy, Radionuclide (Class II - Special Controls, product code KXK).

Submitted by Uromed Corp. (Needham, US). The FDA issued a Cleared decision on May 13, 1999, 323 days after receiving the submission on June 24, 1998.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5730.

Submission Details

510(k) Number K982226 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 24, 1998
Decision Date May 13, 1999
Days to Decision 323 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code KXK — Source, Brachytherapy, Radionuclide
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.5730

Similar Devices — KXK Source, Brachytherapy, Radionuclide

All 150
OncoPatch
K252296 · Oncopatch, Inc. · Dec 2025
IsoSphere
K242818 · Isoaid, LLC · Jul 2025
RadianceTx Radionuclide Brachytherapy Source
K223465 · Radiance Therapeutics, Inc. · Jan 2023
GammaTile
K221539 · Gt Medical Technologies · Nov 2022
Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles
K202267 · Isoray Medical, Inc. · Dec 2020
LV Liberty Vision Model 1 90Yttrium Brachytherapy Source
K193602 · Lv Liberty Vision Corporation · May 2020